48 Gene Solid Tumor Panel Targets Mutations with FDA approved therapeutics for solid tumor ~ Lung, Colorectal, Gastrointestinal Stromal Tumors and Melanoma Molecular Pathology Next Generation Sequencing Panels Single Gene + Small Panel Testing Directed testing for actionable mutations ~ Panels for Lung, Brain, Breast, Colorectal, Endometrial, Gastrointestinal Stromal Tumors, Melanoma Henry Ford Center for Precision Diagnostics 170 Gene Solid Tumor Panel ~ Single nucleotide variants, indels, fusions, splice site variants, amplifications, highly correlate with published COSMIC mutations, Tumor Mutation Burden estimates comparable to Whole Exome Sequencing data 51 Gene Hematolymphoid Neoplasms Panel ~ Acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, myelodysplastic / myeloproliferative neoplasms, systemic mastocytosis and selected genes for lymphoid neoplasms Hematolymphoid Panels ~ DeNovo AML (11 genes) ~ Myeloproliferative Disorders (3 genes) ~ RNA translocation testing (ALL-BCR/ABL p190, APL-PML/RARA, AML-CBFB/MYH11 inv(16), CML-BCR/ABL p210) Gene Fusion Panels (RNA sequencing) ~ Solid Tumor panel (50 genes) ~ Sarcoma panel (26 genes)